Entact Bio, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Entact Bio, Inc. - overview
Established
2022
Location
Watertown, MA, US
Primary Industry
Pharmaceuticals
About
Based in Watertown, US, and founded in 2022 by Sara Buhrlage, Michael Clague, David Komander, Jarrod Marto, Ueli Nachbur, David Sheppard, and Sylvie Urbé, Entact Bio is a preclinical-stage biotechnology company that develops pharmaceutical drugs that enhance the function of beneficial proteins. In December 2022, Entact Bio raised USD 81 million in Series A funding co-led by Qiming Venture Partners, and VenBio Partners, with participation from 4BIO Capital, Abingworth, Arkin Holdings, Brandon Capital Partners, Janus Henderson Investors, Logos Capital, Surveyor Capital, Walter and Eliza Hall Institute of Medical Research. As of December 2022, the firm is being led by its CEO, Victoria Richon. The company uses its proprietary end-to-end Encompass platform to create enhancement-targeting chimeric (ENTAC) molecules to improve protein function in cells by leveraging enzymes known as deubiquitinases to identify disease targets agreeable to ENTAC intervention, select DUB to address the specific target and create specific ENTACs for each target-DUB pair.
The company intends to use the December 2022 funding to advance its proprietary Encompass™ platform for developing enhancement-targeting chimeric (ENTAC™) molecules.
Current Investors
Abingworth, Qiming Venture Partners, Brandon Capital Partners
Primary Industry
Pharmaceuticals
Sub Industries
Biopharmaceuticals, Pharmaceutical Research & Development
Website
https://entactbio.com/
Verticals
Manufacturing
Company Stage
Series A
Total Amount Raised
Subscriber access only
Entact Bio, Inc. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.